HP and metabolic dysfunction-associated steatohepatitis: This comparative analysis suggests that F13A1, haptoglobin, VNN1, and IGFALS are potential markers to detect hepatocyte-derived lipotoxic EVs in plasma and serve as biomarkers for NASH.